PR or Perish – How Media Creates Value for a Bio Startup

JLM-BioCity would like to invite you to: 

PR or Perish – How Media Creates Value for a Bio Startup

Date: Wednesday, September 6, 2017  17:30  

Location: Azrieli College for Engineering, New Building (the building over the underground parking lot, all the way at the far end of the campus), auditorium to be determined.

To succeed, biotech, pharma and biomedical device and digital health companies must create presence and  awareness  for investors, strategic partners and clients. A vital and efficient way to achieve this is through the press and internet. The resulting benefits generate credibility, commercialization and valuation.  If you are not publishing where people can see you, you are missing out on valuable opportunities to improve the chances for your company to succeed. 

This event will present the how, why, and when of a successful public relations strategy. Experts in the field will be joined by professionals who have effectively implemented the process. You will learn from their successes and failures.

Topics to be covered:

• When, where, and what to publish (and what, where, and when not to!)

• Timing of publications throughout the product development cycle

• Article types to consider, and why; look at both home runs and base hits

• Developing a road-map to maximize publication objectives

• PR and your publication program

JLM-BioCity is inviting a number of speakers involved in Public Relations and Media pertaining to the Bio and Healthcare Industry:

• Abigail Leichman, Senior Writer and Associate Editor, Israel21C

• Josh Hextor, COO & VP of Business Development, Oramed Pharmaceuticals

Ronen Segal, COO, Brainsway

• Tsipi Haitovsky, Orchot Consulting 

JLM-BioCity (formerly, JBNF-BioMed) is delighted to announce that this event is sponsored by The Azrieli College of Engineering and AtoBe – Azrieli College of Engineering Startup Entrepreneurship Center.

The presentations will all be given in English.

RVSP to reserve your place. We request 20 NIS upon entrance to the event to help cover costs. JLM-BioCity is anon-profit organization composed of volunteers. Your help is real help.


LOCATION: Azrieli College of Engineering (directions)

JLM-BioCity has created a platform on Jerusalem Bio Innovation, covering news at the different bio companies in the Jerusalem area and from the Jerusalem bio-ecosystem. You can join us on the Linkedin group:

or follow us on the JLM-BioCity site at

JLM-BioCity also is interested in receiving your Bio business news!

About our panelists:

Abigail Leichman, senior writer and associate editor, Israel21C

Abigail Klein Leichman is a senior writer and associate editor of ISRAEL21c, a nonprofit website spotlighting Israeli innovation. For the past 30 years, she also has been writing for publications including The Jerusalem Post; The Record (New Jersey); The Jewish Standard (NJ); The Jewish Week (New York); The Washington Jewish Week; The Parent Paper (NJ); AMIT Woman magazine; Reform Judaism; and Women’s eNews. 

Before making aliyah in 2007, Ms. Leichman was a copy editor and features writer at The Record, the daily newspaper of northern New Jersey, for 14 years and edited its Religion Features and Food pages. 

Josh Hextor, Chief Operating Officer and Vice President of Business Development, Oramed Pharmaceuticals

Josh Hextor joined Oramed Pharmaceuticals in 2013, with over 15 years of prominent leadership, business development, operations know-how and management in the life science sector.

Mr. Hexter was most recently Executive Director of Corporate In-Licensing at BioLineRx (NASDAQ: BLRX).

Prior to joining BioLineRx, he worked in private equity and venture capital where he served as CEO of a VC-backed startup. As CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging business development agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security.

Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University. He also is a certified winemaker from the University of California in Davis.

Tsipi Haitovsky, Orchot Consulting

Tsipi Haitovsky is an experienced global public and media relations consultant specializing in life sciences. She serves as the media liaison/corporate communications representative for a select number of biotech and medical device companies. She helps her clients achieve their business, clinical and/or financial goals through a focused, high profile, results-oriented, strategic public relations/corporate communications program. 

Ms. Haitovsky’s current and past clients include leading biopharma players, medical device companies and academic institutions, from Israel’s private as well as public sectors, such as Compugen (Nasdaq: CGEN), BioLineRx (Nasdaq: BLRX), Yissum Research and Development Company of the Hebrew University, the annual Biomed Conference, BioJerusalem of the Jerusalem Development Authority, BiomX, Mitoconix, cCAM, Betalin Therapeutics, Dreamed Diabetes, Evogene (NYSE: EVGN), Avraham Pharma, Integra Holdings, Atox Bio, Tiltan Phrama, OrSense, Otic Pharma, Goldman Hirsh Partners, TransPharma, Era-Net and more.

Previously, she served as Director of Corporate Communications at Compugen for more than five year where she was responsible for local and international, public relations and marketing communications, and supported investor relations and internal communications efforts. Prior to Compugen, she was International Account Manager, at The Koteret Group, where she performed public and media relations for Israeli hi- tech companies in Europe and the U.S. Previously, she worked as a News Producer for the American TV Network ABC. She has a B.A. in English Literature and an M.A. in Organizational Studies both from the Hebrew University of Jerusalem. 

Show Buttons
Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin
Hide Buttons